Literature DB >> 6802624

Causes of blindness in The Netherlands.

J ten Doesschate.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 6802624     DOI： 10.1007/BF01675857

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN： 0012-4486            Impact factor:   2.379


× No keyword cloud information.
  23 in total

1.  High-dose intravenous corticosteroids for ocular inflammatory diseases.

Authors:  Leon D Charkoudian; Gui-shuang Ying; Siddharth S Pujari; Sapna Gangaputra; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; John H Kempen
Journal:  Ocul Immunol Inflamm       Date:  2012-04       Impact factor: 3.070

2.  Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial.

Authors:  Kevin D Frick; Lea T Drye; John H Kempen; James P Dunn; Gary N Holland; Paul Latkany; Narsing A Rao; H Nida Sen; Elizabeth A Sugar; Jennifer E Thorne; Robert C Wang; Janet T Holbrook
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

3.  Risk of Noninfectious Uveitis with Female Hormonal Therapy in a Large Healthcare Claims Database.

Authors:  Lucia Sobrin; Yinxi Yu; Gayatri Susarla; Weilin Chan; Tian Xia; John H Kempen; Rebecca A Hubbard; Brian L VanderBeek
Journal:  Ophthalmology       Date:  2020-04-27       Impact factor: 12.079

4.  [Vision-threatening complications in childhood uveitis].

Authors:  A Mingels; T Hudde; C Heinz; A Heiligenhaus
Journal:  Ophthalmologe       Date:  2005-05       Impact factor: 1.059

5.  The prevalence of sight-threatening uveitis in Scotland.

Authors:  G J Williams; S Brannan; J V Forrester; M P Gavin; S P Paterson-Brown; A T Purdie; M Virdi; J A Olson
Journal:  Br J Ophthalmol       Date:  2006-08-17       Impact factor: 4.638

Review 6.  The possible impact of uveitis in blindness: a literature survey.

Authors:  M S Suttorp-Schulten; A Rothova
Journal:  Br J Ophthalmol       Date:  1996-09       Impact factor: 4.638

7.  Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.

Authors:  John H Kempen; Michael M Altaweel; Lea T Drye; Janet T Holbrook; Douglas A Jabs; Elizabeth A Sugar; Jennifer E Thorne
Journal:  Ophthalmology       Date:  2015-08-20       Impact factor: 12.079

Review 8.  Chronic non-infectious uveitis in the elderly: epidemiology, pathophysiology and management.

Authors:  Rajen Gupta; Philip I Murray
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

9.  Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.

Authors:  John H Kempen; Mark L Van Natta; Michael M Altaweel; James P Dunn; Douglas A Jabs; Susan L Lightman; Jennifer E Thorne; Janet T Holbrook
Journal:  Am J Ophthalmol       Date:  2015-09-18       Impact factor: 5.258

10.  Degree, duration, and causes of visual loss in uveitis.

Authors:  O M Durrani; N N Tehrani; J E Marr; P Moradi; P Stavrou; P I Murray
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.